MedTrace Logo

Reduction of BK Viremia in Kidney Transplant Patients

NCT04984902 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-04-20

No results posted yet for this study

Summary

Reduction of BK Viremia by treating kidney transplant patients.

Conditions

  • Kidney Diseases
  • Kidney Transplant Infection
  • Kidney Transplant; Complications

Interventions

DEVICE

Extracorporal therapy

Extracorporal therapy

Sponsors & Collaborators

  • University Hospital, Essen

    collaborator OTHER

  • ExThera Medical Europe BV

    lead INDUSTRY

Principal Investigators

  • Bartosz Tyczynski, Dr. · University Hospital, Essen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-02-01
Completion
2023-04-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984902 on ClinicalTrials.gov